Sabine Mueller
University of California, San Francisco · COG Phase I Consortium
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
29
all conditions, ClinicalTrials.gov
NIH grants tied to them
1
NIH RePORTER
Trial papers in ependymoma
0
PubMed author-name match
Trials
Studies that name Sabine Mueller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:04 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07629167 · Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK PathwayUniversity of California, San Francisco · not yet recruiting · Acneiform Drug Eruption, Acneiform Eruptions · principal investigator
- N/ANCT07506239 · Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade GliomaUniversity of California, San Francisco · recruiting · Low-grade Glioma, Recurrent Low Grade Glioma, Low Grade Glioma of Brain · principal investigator
- Ph1NCT07492316 · RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)University of Florida · active not recruiting · Recurrent Medulloblastoma · study chair
- Ph2NCT07447076 · Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)Sabine Mueller, MD, PhD · recruiting · Recurrent Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS · principal investigator
- Ph1/Ph2NCT07389278 · Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)Sabine Mueller, MD, PhD · not yet recruiting · Glioblastoma, High-Grade Glioma (WHO III-IV), High-grade Glioma · principal investigator
- Ph1/Ph2NCT07346157 · Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual DiseaseSabine Mueller, MD, PhD · recruiting · Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent · principal investigator
- Ph2NCT07226453 · Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) EpendymomaUniversity of California, San Francisco · recruiting · Posterior Fossa Ependymal Tumor · principal investigator
- Ph2NCT07110246 · Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade GliomasUniversity of California, San Francisco · recruiting · BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain · principal investigator
- Ph2NCT06861244 · Embryonal Tumor With Multilayered RosettesUniversity of California, San Francisco · recruiting · Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos · principal investigator
- Ph1NCT05887882 · Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain TumorsSabine Mueller, MD, PhD · suspended · Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Neoplasm · principal investigator
- Ph1NCT05478837 · Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated GliomaUniversity of California, San Francisco · terminated · Diffuse Midline Glioma, H3 K27M-Mutant · principal investigator
- Ph2NCT05465174 · Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsSabine Mueller, MD, PhD · recruiting · Craniopharyngioma, Child, Craniopharyngioma, Recurrent Craniopharyngioma · principal investigator
- Ph1NCT05169944 · Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain TumorsUniversity of California, San Francisco · completed · Brain Cancer, Malignant Brain Tumor, Recurrent Brain Tumor · principal investigator
- N/ANCT05057702 · Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and EpendymomaUniversity of California, San Francisco · recruiting · Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent · principal investigator
- Ph2NCT05009992 · Combination Therapy for the Treatment of Diffuse Midline GliomasUniversity of California, San Francisco · recruiting · Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent Diffuse Intrinsic Pontine Glioma · principal investigator
- Ph1NCT04732065 · ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS TumorsSabine Mueller, MD, PhD · recruiting · Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma · study chair
- Ph1NCT04485559 · Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)University of California, San Francisco · recruiting · Recurrent World Health Organization (WHO) Grade II Glioma, Low-grade Glioma, High-Grade Glioma (HGG) · principal investigator
- Early Ph1NCT03893487 · Fimepinostat in Treating Brain Tumors in Children and Young AdultsSabine Mueller, MD, PhD · completed · Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma · principal investigator
- Ph1NCT03749187 · BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV GliomasUniversity of California, San Francisco · active not recruiting · Glioblastoma, IDH1 Gene Mutation, IDH2 Gene Mutation · principal investigator
- N/ANCT03739372 · Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaUniversity of California, San Francisco · completed · Glioma, Glioma of Brain, Cancer · principal investigator
- Ph1/Ph2NCT03566199 · MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine GliomaSabine Mueller, MD, PhD · completed · Diffuse Intrinsic Pontine Glioma · principal investigator
- Ph1NCT03086616 · CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)Sabine Mueller, MD, PhD · completed · Diffuse Intrinsic Pontine Glioma · study chair
- Ph1NCT02962167 · Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRTSabine Mueller, MD, PhD · completed · Medulloblastoma, Childhood, Recurrent, Atypical Teratoid/Rhabdoid Tumor, Medulloblastoma Recurrent · study chair
- Ph1/Ph2NCT02960230 · H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other GliomasSabine Mueller, MD, PhD · completed · Diffuse Intrinsic Pontine Glioma, Glioma, Diffuse Midline Glioma, H3 K27M-Mutant · study chair
- Ph1NCT02947373 · Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain TumorsUniversity of California, San Francisco · completed · Pediatric Brain Tumors · study chair
- N/ANCT02274987 · Molecular Profiling for Individualized Treatment Plan for DIPGUniversity of California, San Francisco · completed · Diffuse Intrinsic Pontine Glioma (DIPG) · principal investigator
- Ph1NCT01922076 · Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine GliomasNational Cancer Institute (NCI) · completed · Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma · principal investigator
- Early Ph1NCT01748149 · Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant GliomasUniversity of California, San Francisco · completed · Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas · principal investigator
- Ph2NCT01734512 · PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in ChildrenUniversity of California, San Francisco · completed · Pediatric Recurrent Progressive Low-grade Gliomas, Pediatric Progressive Low-grade Gliomas · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Phase 0/1 trial of ONC206 - a novel imipridone for children with diffuse midline gliomas and recurrent malignant brain tumorsR01CA266596 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2022 to 2026 · $43,200 awarded in 2026Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Targeting EGFR/FOXG1-mediated resistance to ONC201 in H3K27M-mutant diffuse midline gliomaR01NS124607 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Carl J Koschmann · fiscal years 2022 to 2026Named on NCT05009992
- Pediatric Phase 1/Pilot ConsortiumUM1CA097452 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI Brenda J. Weigel · fiscal years 2009 to 2018Named on NCT01922076
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in ependymoma.